Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.40 |
| ▸ | FGF1 | P05230 | 4/20 | 0.39 |
| ▸ | GJB2 | P29033 | 4/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.37 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.37 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.37 |
| ▸ | IGF2R | P11717 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | FGF2 | P09038 | 3/20 | 0.35 |
| ▸ | VEGFA | P15692 | 3/20 | 0.35 |
| ▸ | HPSE | Q9Y251 | 3/20 | 0.35 |
| ▸ | ENGASE | Q8NFI3 | 1/20 | 0.35 |
| ▸ | SELL | P14151 | 1/20 | 0.34 |
| ▸ | SELP | P16109 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19277314 | 0.86 | GJB2 (0.48) | FGF1GJB2FGF2VEGFAHPSE | |
| SCHEMBL12898703 | 0.83 | GJB2 (0.46) | CD209FGF1GJB2LGALS8LGALS3 | |
| SCHEMBL11886551 | 0.81 | SSTR1 (0.40) | FGF1GJB2FGF2VEGFAHPSE | |
| SCHEMBL14846437 | 0.79 | GJB2 (0.45) | FGF1GJB2LGALS8LGALS3LGALS4 | |
| SCHEMBL28276208 | 0.78 | MAPK1 (0.56) | FGF1GJB2CA1CA2CA9 | |
| SCHEMBL28274960 | 0.78 | MAPK1 (0.56) | FGF1GJB2CA1CA2CA9 | |
| SCHEMBL21080980 | 0.77 | MAPK1 (0.40) | CD209CA1CA2CA9LGALS8 | |
| SCHEMBL13620137 | 0.77 | GJB2 (0.46) | FGF1GJB2LGALS8LGALS3LGALS4 | |
| SCHEMBL14885870 | 0.77 | GJB2 (0.43) | CD209FGF1GJB2LGALS8LGALS3 | |
| SCHEMBL14413981 | 0.77 | MAPK1 (0.51) | GJB2CA1CA2CA9LGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120071441-A1 | 6'-SIALYLLACTOSE SALTS AND PROCESS FOR THEIR SYNTHESIS AND FOR THE SYNTHESIS OF OTHER ALPHA-SIALYLOLIGOSACCHARIDES | INALCO S.P.A. (IT) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071441-A1 | 6'-SIALYLLACTOSE SALTS AND PROCESS FOR THEIR SYNTHESIS AND FOR THE SYNTHESIS OF OTHER ALPHA-SIALYLOLIGOSACCHARIDES | ST6GAL1, FUT6, ST3GAL3 | CD209 581/4885FGF1 2025/4885GJB2 4119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.